Sadia Rahman
Stock Analyst at Wells Fargo
(3.44)
# 2,384
Out of 4,673 analysts
15
Total ratings
69.2%
Success rate
18.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sadia Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Rated: Buy | $30 | $23.36 | +28.42% | 4 | Aug 12, 2026 | |
| MAZE Maze Therapeutics | Rated: Buy | $55 | $29.43 | +86.88% | 4 | Aug 12, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $135 | $111.10 | +21.51% | 6 | Aug 5, 2026 | |
| MDGL Madrigal Pharmaceuticals | Initiated Coverage: Buy | $685 | $516.74 | +32.56% | 1 | Jul 27, 2026 |
Vor Biopharma
Aug 12, 2026
Rated: Buy
Price Target: $30
Current: $23.36
Upside: +28.42%
Maze Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $55
Current: $29.43
Upside: +86.88%
Dianthus Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $135
Current: $111.10
Upside: +21.51%
Madrigal Pharmaceuticals
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $685
Current: $516.74
Upside: +32.56%